Skip to main content

Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells

Molecular and Cellular Biochemistry volume 308, pages 133–139 (2008)Cite this article

Abstract

GPR56 is an atypical G protein-coupled receptor (GPCR) with an unusually large N-terminal extracellular region, which contains a long Ser/Thr-rich region forming a mucin-like stalk and due to this feature, GPR56 is thought to be an adhesion GPCR. Recent studies demonstrate that GPR56 plays a role in brain development and tumorigenesis. Here, we report that human GPR56 undergoes GPS (GPCR proteolytic site)-mediated protein cleavage to generate its extracellular domain as an N-terminal fragment (GPR56-N). We also show that GPR56-N is highly glycosylated with N-linked carbohydrate chains. Mouse Gpr56 is ubiquitously expressed in various tissues, with high levels in kidney and pancreas. GPR56 mRNA is detected in diverse human cancer cells including pancreatic cancer cells PANC-1, Capan-1, and MiaCaPa-2. Interestingly, GPR56 protein is either negligible or undetectable in these pancreatic cancer cells, despite the fact that high levels of GPR56 mRNA are observed. Moreover, we have found that protein levels of GPR56 in pancreatic cancer cells were not affected when cells were treated with a proteasome inhibitor MG132. Taken together, these results define the biochemical properties of GPR56 protein, and suggest that the expression of GPR56 protein is suppressed in human pancreatic cancer cells.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Bockaert J, Pin JP (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723–1729

    PubMed  Article  CAS  Google Scholar 

  2. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650

    PubMed  Article  CAS  Google Scholar 

  3. Fredriksson R, Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67:1414–1425

    PubMed  Article  CAS  Google Scholar 

  4. Fredriksson R, Gloriam DE, Hoglund PJ, Lagerstrom MC, Schioth HB (2003) There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini. Biochem Biophys Res Commun 301:725–734

    PubMed  Article  CAS  Google Scholar 

  5. Hayflick JS (2000) A family of heptahelical receptor with adhesion-like domains: a marriage between two super families. J Recept Signal Transduct Res 20:119–131

    PubMed  CAS  Article  Google Scholar 

  6. Hamann J, Vogel B, Schijndel GM, Lier RA (1996) The seven-span trnasmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184:1185–1189

    PubMed  Article  CAS  Google Scholar 

  7. Shashidhar S, Lorente G, Nagavarapu U, Nelson A, Kuo J, Cummins J, Nikolich K, Urfer K, Foehr ED (2005) GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 24:1673–1682

    PubMed  Article  CAS  Google Scholar 

  8. Xu L, Begum S, Hearn DJ, Hynes OR (2006) GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 103:9023–9028

    PubMed  Article  CAS  Google Scholar 

  9. Piao X, Hill RS, Bodell A, Chang BS, Vanagaite LB, Straussber R, Dobyns WB, Qasrawi B, Winter RM, Innes AM, et al (2004) G protein-coupled receptor-dependent development of human frontal cortex. Science 303:2033–2036

    PubMed  Article  CAS  Google Scholar 

  10. Little KD, Hemler ME, Stipp CS (2004) Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Galpha q/11 association. Mol Biol Cell 15:2375–2387

    PubMed  Article  CAS  Google Scholar 

  11. Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140–156

    PubMed  Article  CAS  Google Scholar 

  12. Iismaa SE, Begg GE, Graham RM (2006) Cross-linking transglutaminases with G protein–coupled receptor signaling. Sci STKE 353:34

    Google Scholar 

  13. Akimov SS, Krylov S, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825–838

    PubMed  Article  CAS  Google Scholar 

  14. Yeo TP, Hruban RH, Leach SD, et al (2002) Pancreatic cancer. Curr Probl Cancer 26:176–275

    PubMed  Article  Google Scholar 

  15. Wobus M, Vogel B, Schmucking E, Hamann J, Aust G (2004) N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Int J Cancer 112:815–822

    PubMed  Article  CAS  Google Scholar 

  16. Krasnoperov V, Lu Y, Buryanovsky L, Neubert TA, Ichtchenko K, Petrenko AG (2002) Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J Biol Chem 277:46518–46526

    PubMed  Article  CAS  Google Scholar 

  17. Davies B, Baumann C, Kirchhoff C, Ivell C, Nubbemeyer R, Habenicht UF, Theuring F, Gottwald U (2004) Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility. Mol Cell Biol 24:8642–8648

    PubMed  Article  CAS  Google Scholar 

  18. Liu M, Parker RM, Darby K, Eyre HJ, Copeland NG, Crawford J, Gilbert DJ, Sutherland GR, Jenkins NA, Herzon H (1999) GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics 55:296–305

    PubMed  Article  CAS  Google Scholar 

  19. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, Muijen GN (1999) TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett 446:292–298

    PubMed  Article  CAS  Google Scholar 

  20. Sud N, Sharma R, Ray R (2006) Chattopadhyay TK, Ralhan R, Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett 233:265–270

    PubMed  Article  CAS  Google Scholar 

  21. Jin Z, Tietjen I, Bu L, Liu LY, Gaur SK, Walsh CA, Piao X (2007) Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 16:1972–1985

    PubMed  Article  CAS  Google Scholar 

  22. Ke N, Sundaram R, Liu G, Chionis J, Fan W, Roger C, Awad T, Grifman M, Yu D, Wong FS, Li QX (2007) Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 6:1840–1850

    PubMed  Article  CAS  Google Scholar 

  23. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901–1908

    PubMed  Article  CAS  Google Scholar 

  24. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120:1046–1054

    PubMed  Article  CAS  Google Scholar 

  25. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu GC, Scarpa A, Croce CM (2006) MicroRNA expression abnormalities in pancreatic end ocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677–4684

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the U.S. National Science Foundation EPSCoR Grant # 0132740 to the state of West Virginia and by a pilot grant from the U.S. National Institutes of Health NCRR Grant # 5P20 RR020180 (PI, Richard Niles, Marshall University). We thank Dr. Christopher Stipp (University of Iowa) for kindly providing us the construct pLXIZ-NFLGPR56, Drs. Andrea McClatchey and Ichiko Saotome (Harvard University) for generously providing us the protein samples from wild-type and ezrin conditional knockout mouse intestines.

Author information

Affiliations

  1. Biomedical Science Graduate Program, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, 25704, USA

    Yue Huang & Guo-Zhang Zhu

  2. Department of Biological Sciences, Marshall University, Huntington, WV, 25755, USA

    Jun Fan & Guo-Zhang Zhu

  3. Columbus Children’s Research Institute, 700 Children’s Dr, Columbus, OH, 43205, USA

    Jing Yang

  4. Department of Pediatrics, the Ohio State University, 700 Children’s Dr, Columbus, OH, 43205, USA

    Jing Yang

Authors
  1. Yue Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guo-Zhang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guo-Zhang Zhu.

Additional information

Yue Huang and Jun Fan contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Huang, Y., Fan, J., Yang, J. et al. Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells. Mol Cell Biochem 308, 133–139 (2008). https://doi.org/10.1007/s11010-007-9621-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-007-9621-4

Keywords

  • GPR56
  • GPCR
  • Post-translational modification
  • GPCR proteolytic site
  • Glycosylation
  • Pancreatic cancer
  • Suppressed expression